Speaker Ready Practice Session:
Dated: November 15th, 2021
Time: 9:20 AM (ET)
CytoImmune will participate in the Stifel 2021 Virtual Healthcare Conference
on
Register for the Stifel 2021 Virtual Healthcare Conference
About CytoImmune Therapeutics, Inc.
CytoImmune Therapeutics is a clinical-stage biotechnology company founded in 2017. It is focused on developing a portfolio of natural killer (NK) immunotherapies designed to utilize the power of a patient’s own immune system to eliminate cancer cells. CytoImmune is moving towards filing the Investigational New Drug (IND) applications for novel immunotherapy programs in hematological and solid malignancies.
Contact:
Name: Alice Mior
Phone: +57 312 8113601
Email: [email protected]
SOURCE: CytoImmune Therapeutics